These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9013365)

  • 21. Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers.
    Brattström C; Säwe J; Jansson B; Lönnebo A; Nordin J; Zimmerman JJ; Burke JT; Groth CG
    Ther Drug Monit; 2000 Oct; 22(5):537-44. PubMed ID: 11034258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients.
    Kahan BD; Wong RL; Carter C; Katz SH; Von Fellenberg J; Van Buren CT; Appel-Dingemanse S
    Transplantation; 1999 Oct; 68(8):1100-6. PubMed ID: 10551636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cyclosporin in children with stable renal transplants.
    Tam JC; Earl JW; Willis NS; Farquhar JE; Nath CE; Knight JF; Hodson EM
    Pediatr Nephrol; 2000 Dec; 15(3-4):167-70. PubMed ID: 11149104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population.
    Potter JM; McWhinney BC; Sampson L; Hickman PE
    Ther Drug Monit; 2004 Aug; 26(4):408-14. PubMed ID: 15257071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole.
    Jeng S; Chanchairujira T; Jusko W; Steiner R
    Transplantation; 2003 Mar; 75(6):792-5. PubMed ID: 12660503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus in pediatric de nova renal transplant patients.
    Hoyer PF; Ettenger R; Kovarik JM; Webb NJ; Lemire J; Mentser M; Mahan J; Loirat C; Niaudet P; VanDamme-Lombaerts R; Offner G; Wehr S; Moeller V; Mayer H;
    Transplantation; 2003 Jun; 75(12):2082-5. PubMed ID: 12829916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
    Napoli KL; Wang ME; Stepkowski SM; Kahan BD
    Ther Drug Monit; 1998 Apr; 20(2):123-33. PubMed ID: 9558125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction.
    Kovarik JM; Kalbag J; Figueiredo J; Rouilly M; Frazier OL; Rordorf C
    J Clin Pharmacol; 2002 Jan; 42(1):95-9. PubMed ID: 11808830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits.
    Ferron GM; Jusko WJ
    Pharm Res; 1998 Dec; 15(12):1888-94. PubMed ID: 9892474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients.
    Holdaas H; Hagen E; Asberg A; Lund K; Hartman A; Vaidyanathan S; Prasad P; He YL; Yeh CM; Bigler H; Rouilly M; Denouel J
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):163-71. PubMed ID: 16625985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.
    Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT
    Eur J Clin Pharmacol; 2001; 56(11):805-11. PubMed ID: 11294370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis.
    Tejani A; Alexander S; Ettenger R; Lerner G; Zimmerman J; Kohaut E; Briscoe DM
    Pediatr Transplant; 2004 Apr; 8(2):151-60. PubMed ID: 15049795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients.
    Emoto C; Vinks AA; Fukuda T
    Ther Drug Monit; 2016 Oct; 38(5):607-13. PubMed ID: 27310200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of sirolimus.
    Mahalati K; Kahan BD
    Clin Pharmacokinet; 2001; 40(8):573-85. PubMed ID: 11523724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.